abiraterone for the treatment of cn1 prostate cancer
Published 2 years ago • 525 plays • Length 1:17Download video MP4
Download video MP3
Similar videos
-
2:31
abiraterone: a step forward in the treatment of prostate cancer
-
2:00
local and systemic therapies for cn1 prostate cancer
-
1:38
5-year follow up of short-course abiraterone and adt for high-risk prostate cancer
-
1:26
current standards and future prospects for the treatment of hormone refractory prostate cancer
-
2:05
abiraterone in metastatic castration-sensitive prostate cancer
-
1:34
combination therapies for the treatment of prostate cancer
-
2:13
head-to-head: tolerability of enzalutamide vs. abiraterone acetate for metastatic crpc
-
3:16
case challenge: radical prostatectomy on a middle-aged man
-
3:14
treatment with abiraterone acetate without steroids in mcrpc
-
0:46
who should get abiraterone in non-metastatic prostate cancer?
-
1:10
abiraterone: a new therapy for metastatic prostate cancer | memorial sloan kettering
-
2:41
quality of life and survival with abiraterone in advanced prostate cancer
-
8:56
abiraterone in metastatic prostate cancer
-
2:41
rob's prostate cancer story and successful treatment with abiraterone
-
1:47
repurposing abiraterone for the treatment of ar salivary gland carcinomas
-
5:16
exciting advances in systemic therapy for prostate cancer: docetaxel and abiraterone
-
7:09
overall survival with abiraterone acetate plus prednisone in peace-1
-
0:18
abirakast - abiraterone acetate tablets
-
2:45
trial of lhrha, abiraterone and enzalutamide: filling an unmet need in prostate cancer therapy